This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.
Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.
Several watch-outs (4) and no clear strengths in the data reviewed.
Points to watch for a moderate profile: see the items marked above.
In plain words
Stock 1727 demonstrates weak profitability with a return on equity of 4.8% and a net margin of 4.4%, while trading at a high P/E ratio of 81.10 compared to the Chemicals median of 18.46. Annual revenue declined -5.5% in 2025 with a negative free cash flow of -434 NT$ million, despite revenue rising 44.6% year on year in Q3 2026. Furthermore, liabilities stand at 44.5% of total assets for Q3 2026, and the company has 2 verified alerts including a cash capital increase announcement on 2026-11-11. Overall, the available data highlights several watch-outs and no clear strengths. The final investment decision rests entirely with the investor.
Written by gemini-3.6-flash from the facts above; every number was checked against them.
Strengths
——
Watch-outs
!P/E 81.10 is well above the Chemicals median of 18.46 (26 listed peers): priced richer than peers. source (Key Stats) →
!Revenue fell -5.5% in 2025; latest quarter Q3 2026: 44.6% year on year. source (Financials) →
!Return on equity 4.8% with a 4.4% net margin: weak profitability. source (Key Stats) →
!Free cash flow was negative in 2025: -434 NT$ million, so spending exceeded operating cash. source (Financials) →
What to check before deciding
?Why is it priced above its peers, and is that premium justified?
?Is the revenue decline temporary or structural?
?What would lift profitability, and how soon?
?What is the spending for, and when does it start paying back?
What the analysis found
!Valuation vs peersP/E 81.10 is well above the Chemicals median of 18.46 (26 listed peers): priced richer than peers. source →
!GrowthRevenue fell -5.5% in 2025; latest quarter Q3 2026: 44.6% year on year. source →
!ProfitabilityReturn on equity 4.8% with a 4.4% net margin: weak profitability. source →
·DebtLiabilities are 44.5% of total assets (Q3 2026). source →
!Cash flowFree cash flow was negative in 2025: -434 NT$ million, so spending exceeded operating cash. source →